Mucormycosis in solid organ transplant recipients (clinical cases and literature review)

Mucormycosis is a severe mycotic infection with high mortality among immunocompromised patients. Its in- cidence in solid organ transplant recipients is 2–8% of all invasive fungal infections. In most cases, it occurs in the late posttransplant period. Risk factors in this patient cohort are graft-versus-host disease (GvHD) and use of immunosuppressive drugs. The article describes clinical cases of mucormycosis and analysis of literature data on the problem of invasive mucormycosis in solid organ transplant recipients. It also reviews the main methods of diagnosis and treatment of the disease according to international guidelines.

1. Gautier SV, Khomyakov SM. Organ donation and transplantation in the Russian Federation in 2022. 15th Report from the Registry of the Russian Transplant Society. Russian Journal of Transplantology and Artificial Organs. 2023; 25 (3): 8–30. https://doi.org/10.15825/1995-1191-2023-3-8-30.

2. Statistics [Shumakov National Medical Research Center of Transplantology and Artificial Organs]. Resource on the Internet (transpl.ru).

3. Kajdas AA, Szostak-Węgierek D, Dąbrowska-Bender M, Normann AK, Søndergaard Linde D. Immunosuppressive Therapy and Nutritional Status of Patients after Kidney Transplantation: A Protocol for a Systematic Review. J Clin Med. 2023 Nov 6; 12 (21): 6955. doi: 10.3390/jcm12216955.

4. Khostelidi SN. Invasive mycoses in recipients of solid organ transplants (literature review). Problems in Medical Mycology. 2023; 25 (4): 3–14. (In Russ). doi: 10.24412/1999-6780-2023-4-3-14.

5. List of rare (orphan) diseases [minzdrav.gov.ru]. Resource on the Internet.

6. Khostelidi SN. Severe fungal infections caused by rare pathogens: dissertation for the degree of Doctor of Medical Sciences. St. Petersburg, 2023; 314.

7. Özbek L, Topçu U, Manay M, Esen BH, Bektas SN, Aydın S et al. COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases. Clin Microbiol Infect. 2023 Jun; 29 (6): 722–731. doi: 10.1016/j.cmi.2023.03.008.

8. Skiada A, Drogari-Apiranthitou M, Pavleas I, Daikou E, Petrikkos G. Global Cutaneous Mucormycosis: A Systematic Review. J Fungi (Basel). 2022; 8 (2): 194. doi: 10.3390/jof8020194.

9. Khostelidi SN, Shadrivova OV, Borzova UV, Desyatik EA, Nicolaeva NG, Bogomolova TS et al. Сlinical and laboratory features of mucormycosis in adults. Problems in Medical Mycology. 2020; 22 (2): 22–28. (In Russ). doi: 10.24412/1999-6780-2020-2-22-28.

10. Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and Diagnosis of Mucormycosis: An Update. J Fungi (Basel). 2020 Nov 2; 6 (4): 265. doi: 10.3390/jof6040265. PMID: 33147877; PMCID: PMC7711598.

11. Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019; 19 (12): e405–e421. doi: 10.1016/S1473-3099(19)30312-3.

12. Temporary guidelines «Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)». Version 10, 02/08/2021. https://static-0.minzdrav.gov.ru.

13. Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020; 71: 1367– 1376. doi: 10.1093/cid/ciz1008.

14. Lanternier F, Sun HY, Ribaud P, Singh N, Kontoyiannis DP, Lortholary O. Mucormycosis in Organ and Stem Cell Transplant Recipients. Clin Infect Dis. 2012; 54 (11): 1–8. https://doi.org/10.1093/cid/cis195.

15. Senoner T, Breitkopf R, Treml B, Rajsic S. Invasive Fungal Infections after Liver Transplantation. J Clin Med. 2023 Apr 30; 12 (9): 3238. doi: 10.3390/jcm12093238.

16. Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother. 2011; 66 (1): i5–i14. https://doi.org/10.1093/jac/dkq437.

17. Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001–2006. Emerg Infect Dis. 2011 Oct; 17 (10): 1855– 1864. doi: 10.3201/eid1710.110087. PMID: 22000355; PMCID: PMC3311117.

18. Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006; 6 (10): 2365–2374. doi: 10.1111/j.1600-6143.2006.01496.x.

19. Lanternier F, Dannaoui E, Morizot G, Elie C, GarciaHermoso D, Huerre M et al. A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005– 2007). Clin Infect Dis. 2012; 54 (1): S35–S43. https://doi.org/10.1093/cid/cir880.

20. Osseis М, Lim C, Salloum C, Azoulay D. Mucormycosis in liver transplantation recipients a systematic review. Surgery Open Digestive Advance. 2023; 10 (11): 100088. https://doi.org/10.1016/j.soda.2023.100088.

21. Rammaert B, Lanternier F, Zahar JR, Dannaoui E, Bougnoux ME, Lecuit M, Lortholary O. Healthcare-associated mucormycosis. Clin Infect Dis. 2012; 54 (1): S44–S54. doi: 10.1093/cid/cir867. PMID: 22247444.

22. Dannaoui E, Schwarz P, Lortholary O. In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. Antimicrob Agents Chemother. 2009; 53 (8): 3549–3551. doi: 10.1128/AAC.00184-09. PMID: 19451295; PMCID: PMC2715618.

23. Barchiesi F, Mazzocato S, Mazzanti S, Gesuita R, Skrami E, Fiorentini A, Singh N. Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases. Liver Transpl. 2015; 21 (2): 204–212. doi: 10.1002/lt.24032. PMID: 25348192.

24. Andes DR, Safdar N, Baddley JW, Alexander B, Brumble L, Freifeld A et al. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the TransplantAssociated Infection Surveillance Network (TRANSNET). Transpl Infect Dis. 2016; 18 (6): 921–931. doi: 10.1111/tid.12613. [PubMed] [CrossRef] [Google Scholar].

25. Mahalmani V, Sarma P, Prakash A, Medhi B. Role of Iron Chelators in Mucormycosis. Indian J Pharmacol. 2021 Jul-Aug; 53 (4): 261–263. doi: 10.4103/ijp.ijp_604_21. PMID: 34414902; PMCID: PMC8411966.

26. Husain S, Sole A, Alexander BD et al. The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary. J Heart Lung Transplant. 2016; 35: 261–282. doi: 10.1016/j.healun.2016.01.007. [PubMed] [CrossRef] [Google Scholar].

27. Alameer R, Nguyen M, Samanta P. Invasive Fungal Infections Associated with COVID-19 Infections in Solid Organ Transplant Recipients. Am J Transplant. 2022; 22 (3): 645. doi: covidwho-2063410.

28. Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis. 2009; 200 (6): 1002–1011. doi: 10.1086/605445. PMID: 19659439.

29. Varotto A, Orsatti G, Crimì F, Cecchin D, Toffolutti T, Zucchetta P, Stramare R. Radiological Assessment of Paediatric Fungal Infections: A Pictorial Review with Focus on PET/MRI. In vivo. 2019; 33 (6): 1727–1735. https://doi.org/10.21873/invivo.11663.

30. Gavaldà J, Meije Y, Fortún J, Roilides E, Saliba F, Lortholary O et al. Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect. 2014; 20 (7): 27–48. doi: 10.1111/1469-0691.12660. PMID: 24810152.

31. Sun HY, Forrest G, Gupta KL, Aguado JM, Lortholary O, Julia MB et al. Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients. Transplantation. 2010; 90 (1): 85–92. doi: 10.1097/tp.0b013e3181dde8fc. PMID: 20626095.